Literature DB >> 19678963

Genetic screening of 104 patients with congenitally malformed hearts revealed a fresh mutation of GATA4 in those with atrial septal defects.

Haruka Hamanoue1, Sri Endah Rahayuningsih, Yuya Hirahara, Junko Itoh, Utako Yokoyama, Takeshi Mizuguchi, Hirotomo Saitsu, Noriko Miyake, Fumiki Hirahara, Naomichi Matsumoto.   

Abstract

We analysed the GATA binding protein 4 gene, or GATA4, along with the NK2 transcription factor related, locus 5 gene, or NKX2.5, to determine their genetic contribution to 104 sporadic patients in Indonesia with congenitally malformed hearts, 76 cases having atrial septal defect and 28 tetralogy of Fallot. We found only 1 novel mutation of GATA4 in those with atrial septal defects. Analysis of the genetic background of the parents of the patient showed for the first time that a new mutation of GATA4 can cause sporadic atrial septal defects. We failed to discover any other mutations of either the GATA4 or NKX2-5 genes, supporting the marked genetic heterogeneity of human congenital cardiac defects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19678963     DOI: 10.1017/S1047951109990813

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  13 in total

1.  Novel NKX2-5 mutations in patients with familial atrial septal defects.

Authors:  Xing-Yuan Liu; Juan Wang; Yi-Qing Yang; Yang-Yang Zhang; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang; Jing-Hao Zheng; Yi-Han Chen
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect.

Authors:  Yi-Qing Yang; Li Li; Juan Wang; Xing-Yuan Liu; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang; Jin-Qi Jiang; Xu Liu; Wei-Yi Fang
Journal:  Pediatr Cardiol       Date:  2011-11-20       Impact factor: 1.655

Review 3.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders.

Authors:  Terence Prendiville; Patrick Y Jay; William T Pu
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

4.  Absence of GATA4 Mutations in Moroccan Patients with Atrial Septal Defect (ASD) Provides Further Evidence of Limited Involvement of GATA4 in Major Congenital Heart Defects.

Authors:  Ihssane El Bouchikhi; Laila Bouguenouch; Fatima Zohra Moufid; Khadija Belhassan; Imane Samri; Amal Chaouti; Mohammed Iraqui Houssaïni; Samir Atmani; Karim Ouldim
Journal:  Eurasian J Med       Date:  2020-10

5.  GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect.

Authors:  Dong Wei; Han Bao; Ning Zhou; Gui-Fen Zheng; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2012-09-09       Impact factor: 1.655

6.  Genetic insights into bicuspid aortic valve formation.

Authors:  Brigitte Laforest; Mona Nemer
Journal:  Cardiol Res Pract       Date:  2012-06-04       Impact factor: 1.866

7.  Mutation spectrum of GATA4 associated with congenital atrial septal defects.

Authors:  Yi-Qing Yang; Juan Wang; Xing-Yuan Liu; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

8.  GATA5 loss-of-function mutations underlie tetralogy of fallot.

Authors:  Dong Wei; Han Bao; Xing-Yuan Liu; Ning Zhou; Qian Wang; Ruo-Gu Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

9.  Associations between two genetic variants in NKX2-5 and risk of congenital heart disease in Chinese population: a meta-analysis.

Authors:  Zhenling Wang; Li Zou; Rong Zhong; Beibei Zhu; Wei Chen; Na Shen; Juntao Ke; Jiao Lou; Ranran Song; Xiao-Ping Miao
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

10.  Effect of Structural Changes in Proteins Derived from GATA4 Nonsynonymous Single Nucleotide Polymorphisms in Congenital Heart Disease.

Authors:  D S Manjegowda; P Karunakar; N B Ramachandra
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.